Latest News & Analysis
stocks
Eli Lilly receives FDA approval to add another oral GLP-1 to market
Wide moat Eli Lilly receives FDA approval for obesity pill.
etfs
ETF investors adding to portfolios during recent volatility
Investors continue to add to their portfolios with these ETFs getting notable inflows, indicating that long-term fundamentals remain solid.
retirement
What you need to consider before retiring early
Both you and your portfolio should be ready for the transition.
personal-finance
Alpha isn't dead. It's being mismeasured.
New research shows smarter portfolio construction—not new factors—is the real edge.
etfs
Unconventional wisdom: ASX ETF and LIC dividend champions
Lessons from ETFs and LICs that have delivered over the last decade.
markets
The refinery problem: A different kind of energy crisis in 2026
Here’s why the energy crisis in Australia is a refinery problem.
stocks
Which of the 3 giant AI IPOs should you buy?
OpenAI, Anthropic, and Databricks are expected to go public this year at massive valuations.
retirement
Should retirees tap their home equity?
Many retirees are cash poor and asset rich. There is a solution with reverse mortgages.
of 664
Viewing 1 to 16 of 10622